Article Information
History
- April 30, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 30, 2021 - 10:24).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- AAG Gabriel*,1,
- JR Atkins*,1,
- RCC Penha1,
- K Smith-Byrne1,
- V Gaborieau1,
- C Voegele1,
- B Abedi-Ardekani1,
- M Milojevic1,
- R Olaso2,
- V Meyer2,
- A Boland2,
- JF Deleuze2,
- D Zaridze3,
- A Mukeriya3,
- B Swiatkowska4,
- V Janout5,
- M Schejbalova6,
- D Mates7,
- J Stojsic8,
- M Ognjanovic9,
- the ILCCO consortium,
- JS Witte10,
- SR SRashkin10,11,
- L Kachuri10,
- R Hung12,
- S Kar13,14,
- P Brennan1,
- A Sertier15,
- A Ferrari15,
- A Viari15,16,
- M Johansson1,
- C Amos17,
- M Foll1 and
- JD McKay1,#
- 1International Agency for Research on Cancer/World Health Organization (IARC/WHO), Genomic Epidemiology branch, Lyon, France
- 2Université Paris-Saclay, CEA, Centre National de Recherche en Génomique Humaine, 91057, Evry, France
- 3Russian N.N. Blokhin Cancer Research Centre, Moscow, The Russian Federation
- 4Nofer Institute of Occupational Medicine, Department of Environmental Epidemiology, Lodz, Poland
- 5Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic
- 6Charles University 1st Faculty of Medicine, Prague Czech Republic
- 7National Institute of Public Health, Bucharest, Romania
- 8Department of Thoracic Pathology, Service of Pathology, University Clinical Centre of Serbia, 11000 Belgrade, Serbia
- 9International Organisation for Cancer Prevention and Research, Belgrade, Serbia
- 10Department of Epidemiology & Biostatistics, University of California San Francisco, San Francisco, CA, USA
- 11Center for Applied Bioinformatics, St. Jude Children’s Research Hospital, Memphis, TN, USA
- 12, Lunenfeld Tanenbaum Research Institute, Sinai Health System
- 13MRC Integrative Epidemiology Unit, University of Bristol, UK
- 14Population Health Sciences, Bristol Medical School, University of Bristol, UK
- 15Synergie Lyon Cancer, Plateforme de bioinformatique ‘Gilles Thomas’ Centre Léon Bérard, 28 promenade Lea et Napoleon Bullukian, 69008 Lyon, France
- 16INRIA Grenoble-Rhône-Alpes, 655 Avenue de l’Europe, Montbonnot-Saint-Martin 38330, France
- 17Institute for Clinical and Translational Research, Baylor College of Medicine, Houston, TX, USA
- ↵#Correspondence JD McKay email: mckayj{at}iarc.fr
↵* Authors contributed equally to this presented work